Search Results
Results found for "Howard Hughes"
- The Hidden Burn: How Internal Misalignment Drains Your Biotech’s Runway
Here’s how it happens: 1️⃣ Duplicated effort 👉 Two teams think they’re building toward the same milestone
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
differential endoplasmic reticulum environment amongst neuronal subtypes Methods & Updates in GPCR Research High-throughput
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
Kenakin’s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors
- 📰 GPCR Weekly News, July 3 to 9, 2023
Research Profiling of basal and ligand-dependent GPCR activities by means of a polyvalent cell-based high-throughput
- G protein-coupled receptor interactions and modification of signalling involving the ghrelin ...
At some sites, such as at somatotrophs, GHSR1a has high constitutive activity.
- In vivo metabolic effects after acute activation of skeletal muscle G s signaling
We also identified two Gs-coupled GPCRs that are endogenously expressed by SKM at relatively high levels
- Scientific Isolation: The Real Reason Early Biotechs Lose Traction
No blow-ups.Just a gradual slide into a world where the internal noise is high, but the external signal
- How Schild Analysis Protects Your Conclusions in GPCR Research
translational pharmacologists, biotech discovery teams, and decision-makers who need concise, credible, high-value
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
. - High-throughput applications Bright and stable fluorescent ligands can be used in HTS,
- How to Use Statistical Methods to Strengthen Every GPCR Drug Discovery Decision
Forge high-value connections in an intimate setting.
- GPCR Allostery: Unlock Hidden Mechanisms and Make Smarter Drug Decisions
That’s exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted
- Adhesion GPCR Consortium Newsletter - May 2024
A small step toward leveling the playing field.
- 📰 GPCR Weekly News, January 30 to February 5, 2023
The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards
- Odorant receptors – a bit of smell for drug discovery
The development of antibodies directed towards an OR could either drive receptor inactivation or activation
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
Where high-throughput screening saw chaos, Ajay saw patterns waiting to be decoded.
- Curve Shifts Don’t Lie, But Your Eyes Might
For high-throughput screens where sensitivity isn’t critical, you’ll save time by running fewer replicates
- 📰 GPCR Weekly News, June 19 to 25, 2023
Structural and Molecular Insights into GPCR Function Structure-Activity Relationship Study of the High-Affinity
- TM5-TM6: structural switches that modulate the coupling of serotonin receptors to Gs or Gi
Prior to this report we did not know how different serotonin receptor subtypes which share high sequence
- 📰 GPCR Weekly News, March 4 to 10, 2024
Cone Pigment Activation Molecular dynamics-based identification of binding pathways and two distinct high-affinity
- HBx induces hepatocellular carcinogenesis through ARRB1-mediated autophagy to drive the G 1/S cycle
S-transferase; HCC: hepatocellular carcinoma; HBV: hepatitis B virus; HBx: hepatitis B virus X protein; HMGB1: high
- Understanding Enzyme Inhibition In GPCR Discovery Programs
GPCR Premium: Sneak Peek Here’s a curated, high-signal preview of what Premium Members get this week—no
- The mouse cytomegalovirus G protein-coupled receptor homolog, M33, coordinates key features of ...
dependent signalling correlated with reduced mobilisation of lytically-infected DC to draining lymph node high
- Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success
A high-affinity ligand often has higher efficacy, but the relationship is not linear.
- How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)
GPCR Premium: Sneak Peek Here’s a fast, high-level preview of what Premium Members are unpacking this
- Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right
here ➤ Discovery on Target 2025 – GPCR Speaker Spotlight DOT 2025 (Sept 22–25, Boston) is set to be a high-signal
- Exploring the Breakthroughs in GPCR Research
Herbal Compounds as Potential Drugs for Chronic Myeloid Leukemia Methods & Updates in GPCR Research High-throughput
- 📰 GPCR Weekly News, June 24 to 30, 2024
site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential GPCR therapeutics A high-affinity
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
translational success: How post-COVID insights and unconventional decision-making shaped Serafini’s high-impact
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
Insomnia Patient in its Phase 3 Clinical Trial of Daridorexant in South Korea Septerna Touches New High
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Recently, several high-throughput screening (HTS) assays for ERK activation have been developed, each



















